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Puberty is a tightly regulated process that leads to reproductive capacity. Kiss1 neurons are crucial
in this process by stimulating GnRH, yet how Kiss1 neurons are regulated remains unknown.
Substance P (SP), an important neuropeptide in pain perception, induces gonadotropin release in
adult mice in a kisspeptin-dependent manner. Here, we assessed whether SP, through binding to
its receptor NK1R (neurokinin 1 receptor), participates in the timing of puberty onset and fertility
in the mouse. We observed that 1) selective NK1R agonists induce gonadotropin release in pre-
pubertal females; 2) the expression of Tac1 (encoding SP) and Tacr1 (NK1R) in the arcuate nucleus
is maximal before puberty, suggesting increased SP tone; 3) repeated exposure to NK1R agonists
prepubertally advances puberty onset; and 4) female Tac1/mice display delayed puberty; more-
over, 5) SP deficiency leads to subfertility in females, showing fewer corpora lutea and antral
follicles and leading to decreased litter size. Thus, our findings support a role for SP in the stim-
ulation of gonadotropins before puberty, acting via Kiss1 neurons to stimulate GnRH release, and
its involvement in the attainment of full reproductive capabilities in female mice. (Endocrinology
156: 2313–2322, 2015)
Reproductive function is controlled by the hierarchicalinterplay of central and peripheral factors that ulti-
mately dictate the timing and pattern of GnRH release
from puberty onset onwards. However , the exact mech-
anisms that communicate this information to GnRH neu-
rons are poorly understood. Hypothalamic Kiss1 neurons
(encoding kisspeptins) have been posed as the main con-
veyors of these regulatory factors by translating their in-
formation to effect congruent GnRH pulses (1). Indeed,
loss-of-functionmutations in theKiss1 orKiss1r (kisspep-
tin receptor) genes lead to hypogonadotropic hypogonad-
ism (HH) in mice and humans (2–5).
Recently, an increasing number of direct hypothalamic
modulators of Kiss1 neurons have been identified, uncov-
ering a complex system of neuroendocrine factors that
ensure proper gonadotropic function. In this context,
Kiss1 neurons in the arcuate nucleus (ARC) coexpress
dynorphin (inhibitory) and neurokinin B (NKB) (stimu-
latory) (6, 7), which have been proposed to act in a coor-
dinated fashion to shape kisspeptin pulses. Interestingly,
humans bearing inactivating mutations in TAC3 or
TACR3 (encoding NKB and the receptor of NKB, neuro-
kinin 3 receptor (NK3R), respectively) also display HH,
characterized by absence of puberty and infertility (8–11).
Moreover, mice bearing a nullTac2 orTacr3 gene display
delayed puberty and subfertility (12, 13) and chronic
treatment ofmice and ratswith specificNK3Rantagonists
delays puberty onset (14, 15). Of note, this action of NKB
in the central control of the gonadotropic axis is kisspeptin
dependent (16, 17).
Importantly,NKBbelongs to a family of closely related
peptides termed tachykinins, which comprises also sub-
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stance P (SP) and neurokinin A (NKA), both encoded by
theTac1gene (18).Anumberof studies have associatedSP
with pain perception and inflammatory processes in the
brain (19) as well as with psychiatric disorders (20). Al-
though no human mutations in the genes encoding these
ligands (TAC1) or their receptors (TACR1 and TACR2,
respectively) have been correlated with reproductive dis-
orders yet, both SP and NKA have been reported to stim-
ulate the gonadotropic axis in several species (18, 21–30)
in a kisspeptin-dependent manner (25) and SP is coex-
pressed in a subset of Kiss1 neurons in the human (31).
Indeed, we recently demonstrated that SP, but not NKA,
may act directly on Kiss1 neurons to stimulate gonado-
tropin release, along with NKB, because a subpopulation
of these neurons expresses the SP receptor, neurokinin 1
receptor (NK1R) (25), in agreement with recent studies
showing activation of Kiss1 neurons by SP (23).
Thus, based on the potent stimulatory action of gonad-
otropin release that we have previously observed after
stimulation of the SP receptor (25); in this work, we fo-
cused on deciphering the potential role of SP, as a direct
kisspeptin stimulator, in the control of puberty onset and
reproductive function through a series of functional tests
and genetic studies in the female mouse.
Materials and Methods
Mice
Prepubertal wild-type (WT) female C57Bl/6 mice were pur-
chased from Charles River Laboratories International, Inc.
Tac1-deficient (Tac1/) mice and WT littermates were gener-
ated by crossing Tac1/ (heterozygous) acquired from The
Jackson Laboratory. A detailed characterization of this mouse
model can be found elsewhere (32). In addition, we have further
confirmed the absence of Tac1 mRNA in mediobasal hypotha-
lamic samples of adult male mice by real-time quantitative PCR
(data not shown). All experiments were approved by the Har-
vard Medical Area Standing Committee on Animals in the Har-
vardMedical School Center for Animal Resources and Compar-
ative Medicine. Mice were maintained in a 12-hour light, 12-
hour dark cycle and were fed a standard rodent diet.
Reagents
The NK1R agonist (GR73632, termed NK1R-A in this
study), a highly selective SP receptor agonist (EC50 NK1R 
4nM; NK2R 960nM; and NK3R 1000nM) (25), was pur-
chased from Tocris. The doses of GR73632 (600 pmol in 5 L
of physiological saline for intracerebroventricular [icv] and 3
nmol in 50 L for ip) were selected on the basis of previous
references showingeffective actionof these compounds to induce
gonadotropin responses in mice (25).
Experimental design
Experiment 1. Effect of central NK1R-agonist admin-
istration on gonadotropin release in prepubertal fe-
male mice
Female mice (postnatal d [p]25, n  10/group) were anes-
thetized with isoflurane anesthesia and received 5-LGR73632
(NK1R-A, 600 pmol) or vehicle (0.9% NaCl) through an icv
injection, as previously described (33). Briefly, mice were anes-
thetizedwith isofluranedeliveredbyavaporizer.Uponachieving
a surgical plane of anesthesia, a small hole was bored in the skull
1 mm lateral and 0.5 mm posterior to bregma with a Hamilton
syringe attached to a 27-gauge needle fitted with polyethylene
tubing, leaving 3.5mmof the needle tip exposed.Once the initial
hole was made, all subsequent injections were made at the same
site. Mice were allowed to recover for at least 2 days before
treatment. For icv injections, mice were anesthetized with iso-
flurane for a total of 2–3 minutes, during which time 5 L of
solution were slowly and continuously injected into the lateral
ventricle. The needle remained inserted for approximately 60
seconds after the injection to minimize backflow up the needle
track.Mice typically recovered from the anesthesiawithin3min-
utes after the injection. Blood samples (200L)were collectedby
retroorbital bleeding (34) 25 minutes after injection (flowchart
in Supplemental Figure 1). The dose and time of collection were
selected based on our previous studies (25).
Experiment 2. Expression of Tac1 and Tacr1 in the
mediobasal hypothalamus (MBH) of female mice
across postnatal development
Weaimed to determinewhether there are changes in the expres-
sion of Tac1 and Tacr1 during the postnatal development in the
MBH as the site that includes the ARC as the likely hypothalamic
area where the mechanisms that initiate puberty take place. Intact
infantile (p10), early juvenile (p15), late juvenile (p22),peripubertal
(p30), and adult in diestrous (p60) females were killed and brains
were collected. The hypothalamic tissue was sectioned using a cor-
onal brain matrix (Braintree Scientific) and immediately frozen in
liquid nitrogen and stored at80°C. Briefly, The ARC fragments
were isolated fromeach section under a dissectionmicroscopewith
fine instrumentsby2bilateralparasagittal cuts, each0.5mmlateral to
the midline between the optic chiasm and the posterior commissure,
and 1 horizontal cut 1mmdorsal of the ventral surface, yielding total
tissue sizes of approximately 1 mm3 that were immediately frozen in
liquidnitrogen and stored at80°C (35). It is possible that part of the
ventromedial hypothalamus (VMH) may have been dissected along
with the ARC by this approach; therefore, we have called this area
MBH. The expression of theTac1 andTacr1 genes in theMBHwas
assessed by quantitative real-time PCR (n 3/group).
Experiment 3. Effects of repeated stimulation of pre-
pubertal female mice with NK1R-A
WT females obtained fromCharles River Laboratories Inter-
national at p21 were injected ip with 3 nmol GR73632
(NK1R-A) in 50 L every 12 hours from p22 to p34 (n 
9/group). Of note, the NK1R-A crosses the blood brain barrier
(36); therefore, to facilitate the repeated treatment of the ani-
mals, ip injections were performed using the highest dose previ-
ously tested inmice (3 nmol). Vaginal opening (VO), as an indirect
marker of circulating estradiol (E2) levels and therefore puberty,
2314 Simavli et al SP Regulates Puberty Onset and Fertility. Endocrinology, June 2015, 156(6):2313–2322
D
ow
nloaded from
 https://academ
ic.oup.com
/endo/article-abstract/156/6/2313/2423340 by Pam
ukkale U
niversity user on 23 D
ecem
ber 2019
wasmonitoreddaily.The experimentwas extendeduntil oneof the
2 groups reached 80% (or above) of VO. That day, body weights
(BWs) of the animalsweremeasuredbefore the treatment, and they
were euthanized 15 minutes after the last NK1R-A injection (Sup-
plemental Figure 1). Gonadal weights were measured and trunk
blood collected for hormonal determination.
Experiment 4. Assessment of the pubertal development
of Tac1 null femalemice
Littermate Tac1/ (WT), Tac1/ (heterozygous, HET),
and Tac1/ (knockout, KO) females (n 8–12 in each group)
weremonitored daily fromp25 for: 1) BW, 2) progression toVO
(as indicated by complete canalization of the vagina), and 3)
timing of first estrus (first d with cornified cells determined by
daily [in the morning] vaginal cytology after the d of VO) (Sup-
plemental Figure 1).
Experiments 5 and 6. Analysis of the reproductive
phenotype of adult Tac1 null female mice
In experiment 5, we characterized the estrous cyclicity of
Tac1 null mice and controls by daily vaginal cytology for 4–5
weeks (Supplemental Figure 1). Cytology sampleswere obtained
every morning (10 AM) and placed on a glass slide for determi-
nation of the estrous cycle under the microscope as previously
described (37). In addition, we performed a fertility assessment
by breeding adult Tac1/ or WT females with WT male pre-
viously proven to father litters (n6/group).The time to the first
litter and number of pups per litter was monitored.
Experiment 6
In order to further assess the ovarian physiology of these
animals, a histological study was performed on ovaries from
adult (diestrus) WT and Tac1/ mice (n  5/group). Ovaries
were collected,weighedand fixed inBouin’s solution.The tissues
were embedded in paraffin and sectioned (10 m) for hematox-
ylin and eosin staining (HarvardMedical School Rodent Pathol-
ogy Core) and images acquired under 4 magnification. The
ovaries were analyzed for presence and type of follicles and for
presence of corpora lutea (CLs) per section. Each value repre-
sents the number of follicles and CLs of 1 representative section
from the middle line of one ovary per animal.
Experiment 7. Characterization of the postgonadec-
tomy response of gonadotropins
LH and FSH levels were measured in intact (diestrus in the
morning) WT and Tac1/ mice compared with 1 week after
bilateral ovariectomy (OVX) (n  5/group) (Supplemental Fig-
ure 1). Blood sampleswere collectedby retroorbital bleeding and
serum stored at 20°C until hormonal determination.
Hormone measurements
Serum LH and FSH were measured using the Luminex (Lu-
minex Corp) system analysis. Because of the small samples of
blood obtained from the mice during the study, only single mea-
surements were performed using 8 L of serum per individual
time point for each animal. The LH was analyzed using xMap
technology (Millipore) with the mouse pituitary panel. A stan-
dard curve was generated using 5-fold serial dilutions of the
LH/FSH standard cocktail provided by the vendor. Standards
and samples were incubated with the antibody-coated beads on
a microplate shaker overnight at 4°C and washed 3 times using
a vacuum manifold apparatus. Detection antibody was then
added to thewells and incubated on amicroplate shaker at room
temperature for 30 minutes. Streptavidin-phycoerythrin solu-
tion was then added, and an additional 30-minute incubation at
room temperature was performed using the microplate shaker.
Plates were then washed 3 times, and sheath fluid was added to
each well. Beads were resuspended on the microplate shaker for
5 minutes. Plates were then read on the Luminex 200IS system
using xPonent software (Luminex Corp). Data were analyzed
using5-parameter logistic curve fitting.Theminimumdetectable
concentration (pg/mL) for LHwas 1.9 and for FSHwas 9.5. The
intraassay coefficient of variation was less than 15%.
Quantitative real-time RT-PCR
Total RNA from theMBHwas isolated using TRIzol reagent
(Invitrogen) followed by chloroform/isopropanol extraction.
RNAwas quantified using NanoDrop 2000 spectrophotometer
(Thermo Scientific), and 1 m of RNA was reverse transcribed
using Superscript III cDNA synthesis kit (Invitrogen). Quanti-
tative real-time PCR assays were performed on an ABI Prism
7000 sequence detection system and analyzed using ABI Prism
7000SDS software (AppliedBiosystems).The cycling conditions
were as follows: 2 minutes of incubation at 50°C, 10 minutes of
incubation at 95°C (hot start), 40 amplification cycles (95°C for
15 s, 60°C for 1 min, and 45 s at 75°C, with fluorescence de-
tection at the end of cycles 3–40), followed by melting curve of
the amplified products obtained by ramped increase of the
temperature from 55°C to 95°C to confirm the presence of
single amplification product per reaction. The Tac1 mRNA
NM_009311 (primers, 5-TTTCTCGTTTCCACTCAACT-
GTT-3 and 5-GTCTTCGGGCGATTCTCTGC-3) andTacr1
mRNA NM_009313 (primers, 5-TTGTGCAACCTACCTG-
GCAAA-3 and 5-CCACTGTATTGAATGCAGCCAT-3)
were detected using SYBRGreenMix (Bio-Rad) according to the
manufacturer’s instructions. The data were normalized using
L19 primers as an internal control (38), and expressed as fold-
change relative to p10.
Statistical analysis
All data are expressed as the mean SEM for each group. A
2-tailed unpaired Student’s t test or a one- or two-way ANOVA
test was used followed by Newman-Keuls or Tukey’s post hoc
tests, respectively, to assess variation among experimental
groups. Significance level was set at P 	 .05. All analyses were
performed with GraphPad Prism Software, Inc.
Results
Experiment 1. Effect of central NK1R-agonist
administration on gonadotropin release in
prepubertal female mice
Our previous studies have documented potent LH and
FSH release after NK1R-A treatment in adult mice (25).
Therefore, the purpose of experiment 1 was to confirm that
prepubertal female mice are also able to respond to an SP
receptor agonist. In this context, icv administration of
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NK1R-A (600 pmol) was able to significantly stimulate LH
(vehicle, 0.390.05 ng/mLvsNK1R-A, 2.030.59; t(7)
2.43; P  .005) and FSH (vehicle, 0.66  0.09 ng/mL vs
NK1R-A, 1.40  0.20; t(9)  2.99; P  .015) release in
prepubertal femalemice25minutesafter injection(Figure1).
Experiment 2. Expression of Tac1 and Tacr1 in the
MBH of female mice across postnatal development
Geneswith documented stimulatory action of the gonad-
otropic axis prepubertally, eg, Kiss1 and Tac2, display sig-
nificantlyhigher expression in thehypothalamusbeforephe-
notypic manifestations of puberty such as VO in females or
preputial separation in males (14, 39). Thus, in experiment
2, we hypothesized that the expression profile of the genes
encoding the SP/NK1R system (Tac1 and Tacr1, respec-
tively)wouldalsobeaugmented in thehypothalamusduring
this developmental period, if they play roles in the activation
of theHPG axis at the onset of puberty.We have previously
documented a predominant expression of Tac1 in the ARC
and the VMHnuclei within the hypothalamus and the pres-
enceofTacr1 inhalf ofKiss1neurons in theARC(25).Thus,
given the predicted role of ARC Kiss1 neurons in triggering
puberty onset, we focused on a study of the expression of
Tac1andTacr1genes in theMBH(as likely directmediators
of kisspeptin activation). Tac1 expression was significantly
higher in the MBH at p15 and p22 (Figure 2A) compared
with infantile (p10) and adult (p60) ages (F(4,13) 6.34;P
.005). Similarly, Tacr1 expression at p15 is significantly
higher than at peripubertal or adult ages (F(4,13) 4.52;P
.02) (Figure 2B).
Experiment 3. Effects of repeated stimulation of
prepubertal female mice with NK1R-A
The ability of prepubertal animals to respond to
NK1R-Awith significantly increased gonadotropin levels
(experiment 1) and the apparently higher tone of the SP/
NK1Rsystemat the timeof puberty initiation (experiment
2) led us to propose that, if SP induces puberty onset,
exogenous administration of NK1R-A to mice at an early
age (thus increasing SP tone) would lead to advanced pu-
berty. Thus, we observed that chronic NK1R-A adminis-
tration from p22 significantly advanced puberty onset as
indicated by the advanced timing of VO (Figure 3A), also
represented in Figure 3B as the day at which 50% of the
animals in each group reached VO (vehicle, 33.17  0.4
mg vs NK1R-A, 31.60  0.5 mg; t(9)  2.45; P  .04);
higher uterine (vehicle, 28.22 1.8 vs NK1R-A, 41.11
4.20; t(16) 2.77; P .01) and ovarian weights (vehicle,
8.87 0.5 mg vs NK1R-A, 12.89 1.1 mg; t(16) 3.19;
P  .005) (Figure 3, C and D); and higher LH levels (ve-
Figure 1. Serum LH (left panel) and FSH (right panel) values of
prepubertal female mice 25 minutes after central icv injection of 600
pmol GR73632 (NK1R-A) or vehicle (VEH). Statistical analysis was
performed using a 2-tailed t test (*, P 	 .05 compared with vehicle-
treated controls).
Figure 2. Expression profile of Tac1 (A) and Tacr1 (B) in the MBH of
female mice across postnatal development. One-way ANOVA 
Newman-Keuls post hoc test was performed to compare all groups.
Different letters indicate significantly different values (P 	 .05).
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hicle, 0.22 0.01 ng/mL vsNK1R-A, 0.36 0.02 ng/mL;
t(15)  4.34; P 	 .001) (Figure 3E). Of note, BW and
circulating leptin levels were similar in the control and
treated groups (Figure 3, F and G), indicating that there is
no metabolic contribution to this phenotype at this age.
Experiment 4. Assessment of the pubertal
development of Tac1 null female mice
Based on the strong evidence from experiments 1–3,
indicating that the SP/NK1R system plays a role in the
control of puberty onset in the mouse, we aimed to char-
acterize the reproductive phenotype of mice with congen-
ital absence of SP (Tac1/). We observed that both
Tac1/ (HETs) and Tac1/ (KOs) mice displayed a sig-
nificant delay in VO compared with Tac1/ (WT) (WT,
31.1 0.5 d; HET, 33.83 0.69 d; KO, 35.90 0.64 d;
F(2,29)  1057; P 	 .0001) (Figure 4, A and B). Once
animals reachedVO,dailyvaginal smearsweremonitored to
determine the age of first estrus, which showed a trend to be
delayed in KO mice compared with WT, but did not reach
statistical significance (WT, 37.00 1.2 d vs KO, 39.00
0.6 d; t(12) 1.594; P .137) (Figure 4C). Of note, the BW
of the animals, measured on p32 (when 100% of WT mice
had reached VO), was not different between groups, indi-
cating that, at that age, the delay inVO is not attributable to
a lower BW (F(2,28)  0.13; P .88) (Figure 4D). Of note,
WT littermates in this experiment displayedVOat an earlier
age than WT mice purchased at p21 from Charles River
Laboratories International in experiment 3; nonetheless, the
presence of the corresponding controls in each experiment
validates the results.
Experiments 5 and 6. Analysis of the reproductive
phenotype of adult Tac1 null female mice
Experiments 3 and 4 indicated a likely role of SP in the
timing of puberty onset; therefore, in order to determine
whether SP also plays a role in the attainment of fertility,
the reproductive phenotype of Tac1
null female mice was assessed in ex-
periments 6 and 7. WT and HET
mice displayed regular cycles
(pooled and referred to as controls)
(Figure 5A); interestingly, Tac1/
mice exhibited a sustained phase of
estrus after the first estrus (Figure 5,
B and C) that was significantly lon-
ger than that observed in control an-
imals (n  5–8/group) (control,
6.571.17dvsKO,13.671.08d;
t(11)  4.38; P  .001). However,
after this period, Tac1 null mice ini-
tiated cyclicity in most cases with
similar cycle lengths (from estrus to
Figure 4. Pubertal progression of Tac1/ female mice. A, Percentage of mice showing VO at
each age. B, Mean age of VO. C, Age of first estrus. D, BW at p32. One-way ANOVA followed by
Newman-Keuls post hoc test was performed to compare all groups. Different letters indicate
significantly different values (P 	 .05).
Figure 3. Repeated ip stimulation (every 12 h) of female mice with GR73632 (NK1R-A) from p22 to p34. Progression of VO (A), age (postnatal d)
until 50% of the animals in each group displayed VO (B). At p34, uterine weight (C), ovarian weight (D), serum LH levels (E), BW (F), and serum
leptin levels (G) were measured. Statistical analysis was performed using a 2-tailed t test (*, P 	 .05; **, P 	 .01; ***, P 	 .001).
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estrusof thenext cycle) to control animals (control, 5.71
0.16 d vs KO, 6.00  0.33 d; t(26)  0.77; P  nonsig-
nificant) (Figure 5D).
In order to further assess the ovarian physiology of these
animals, a histological studywas performedonovaries from
adult (diestrus) WT and Tac1/ mice. Tac1/ mice had
smaller ovaries with fewer CLs (control, 2.75 0.85 CL vs
KO, 0.78 0.32CL; t(11) 2.70; P .02) (Figure 6, A and
B) and fewer antral follicles (AFs) (control, 3.50 0.86 AF
vsKO,1.000.37; t(9)3.09;P .01) (Figure6,AandC).
Figure 5. Estrous cyclicity of control (A) and Tac1/ (B) female mice. C, Time from first estrus to initiate regular cyclicity. D, Cycle length (from
estrus to the next estrus). Statistical analysis was performed using a 2-tailed t test (**, P 	 .01 compared with controls).
Figure 6. A, Ovarian histology of WT and Tac1/ adult mice. B, Number of corporal lutea per ovary. C, Number of AFs per ovary. D, Litter sizes
of WT and Tac1/ female mice mated with adult experienced WT males. Blue arrows are examples of AFs. Statistical analysis was performed
using a 2-tailed t test (*, P 	 .05 compared with controls).
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These data suggested possible subfertility in the Tac1
knockout animals. Hence, we conducted a further fertility
assessment bybreedingWTandTac1/ femalemice (n
6) with experienced adult WTmales. Tac1/mice deliv-
ered a significantly lower number of pups per litter (WT,
9.00 0.36 pups/litter vs KO, 5.80 1.11 pups/litter; t(9)
 2.95; P .02) (Figure 6D). Of note, all females in both
groups achieved pregnancywith no significant differences
in the time to deliver the pups (data not shown).
Experiment 7. Characterization of the
postgonadectomy response of gonadotropins
Experiments 4–6 indicate a likely reproductive impair-
ment inTac1/mice that leads to a subfertile phenotype.
In order to address whether the absence of SP leads to a
diminished ability of these animals to release kisspeptin
(and/or GnRH), wemeasured LH and FSH levels in intact
(diestrus) WT and Tac1/ mice compared with 1 week
after OVX, as a model of elevated gonadotropin release.
Control (WT) andTac1nullmicewere ovariectomized for
1 week, and serum LH and FSH levels were compared
between groups. Interestingly, both groups of animals dis-
played a similar compensatory rise of gonadotropin levels
with no significant difference between the 2 genotypes
(F(1,18)  0.73; P  .40) (Figure 7), suggesting normal
increases in kisspeptin and GnRH release after estrogen
withdrawal.
Discussion
Understanding the neuroendocrine events that determine
the timing of puberty onset, and the subsequent achieve-
mentof reproductive capacity, hasbeenamatter of intense
research in recent decades; however, althoughanumberof
stimulatory and inhibitory factors have been reported to
interplayduring thisdevelopmentalprocess (40), the exact
mechanism/s that trigger sexual maturation remain in-
completely understood.Here,we provide evidence that SP
also participates in the pubertal activation of the gonad-
otropic axis in the mouse. We have previously docu-
mented that: 1) agonists of the SP receptor stimulate go-
nadotropin release in adult mice and in prepubertal rats
(25, 27); 2) this action is kisspeptin dependent (25); and 3)
the gene encoding the SP receptor (Tacr1) is expressed in
approximately 50% of Kiss1 neurons in the ARC and
33%ofKiss1 neurons in the anteroventral periventricular
nucleus (25). These data are consistent with a direct effect
of SP on Kiss1 neurons, as recently demonstrated through
electrophysiological studies (23).
Kiss1neuronsare themaingatekeepersof reproduction
and loss-of-function mutations in the Kiss1 or Kiss1r
genes lead to the absence of reproductive maturation (1).
Considerable interest has emerged to identify the factors
involved in the control of kisspeptin release as the putative
central regulator of the gonadotropic axis. In this context,
the tachykinin NKB has been reported to stimulate kiss-
peptin prepubertally (15) and the expression of Tac2 (en-
coding NKB) increases before Kiss1 (14), suggesting a
likely role of this tachykinin in the pubertal activation of
kisspeptin-GnRH secretion, as also supported by human
studies describing HH in patients with impaired function
of the NKB/NK3R system (8, 9).
In this study, we demonstrate that the activation of the
receptor of SP, a counterpart of NKB in the tachykinin
family, is able to accelerate the onset of puberty in mice,
suggesting that the NK1R is present, and functional, dur-
ing this developmental period; moreover, the expression
of the genes encoding SP and the SP receptor are signifi-
cantly higher at the time of the initiation of puberty onset
than they are at earlier or later stages of postnatal devel-
opment. This suggests the existence of a higher SP tone,
and greater sensitivity to hypothalamic SP, at the time of
puberty initiation, putatively leading to an increase in
GnRH pulses and activation of the gonadotropic axis.
Figure 7. Serum LH (upper panel) and FSH (lower panel) values of
adult intact and OVX (1 wk) WT and Tac1/ female mice. Statistical
analysis was performed using two-way ANOVA followed by Tukey’s
post hoc test. Different letters indicate significantly different values
(P 	 .05).
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Interestingly, unlike Kiss1 and Tac2, the genes encoding
the SP/NK1R system decrease in the ARC of the mouse
after the initiation of puberty, perhaps indicating a pre-
dominant role of this molecule early in puberty onset. In-
deed, supporting this contention, we have demonstrated
in the present study that 1) stimulation of the SP receptor
(NK1R) during this prepubertal period advances puberty
onset, possibly through the early activation of Kiss1 neu-
rons, resembling previous kisspeptin treatments in prepu-
bertal rodents (41); and 2) congenital SP-deficiency
(Tac1/ mice) leads to delayed puberty. Of note, due to
the limitation of chronic animal manipulations before
weaning, the repeated injections of NK1R-A were per-
formed from p22 onwards, which is beyond the reported
peak of Tac1 and Tacr1 expression. Still, this treatment
successfully advanced puberty onset, probably due to the
sustained higher activation of NK1R compared with con-
trols. Admittedly, although p30 has been widely consid-
ered as a peripubertal age based on external signs of pu-
berty onset in rodents, ie, VO, the initiation of puberty
onset centrally must occur at an earlier age, thereby lead-
ing to the increase of GnRH release that will evoke the
appearance of these secondary sexual signs. However, the
timing of the appearance of these central mechanisms re-
mains largely unknown, and it is very likely that it occurs
during what is typically termed the juvenile state, around
the time that Tac1 and Tacr1 show maximal expression.
Interestingly,NK1Rhas been described in bothKiss1 neu-
ronal populations (ARC and anteroventral periventricu-
lar nucleus) as well as in a subset of GnRH neurons (25).
Therefore, whether the action of SP in the regulation of
puberty onset occurs on one, or all, of these neuronal
groups remains to be deciphered.
In addition, SP is critical for the maintenance of proper
reproductive function. SP null female mice required more
time to initiate estrous cyclicity, during which they re-
mained in constant estrus. This suggests that although E2
is produced by the ovary, this alone may not be sufficient
to trigger an LH surge and, therefore, ovulation. Indeed,
histological examination of the ovaries revealed fewer
numbers of CLs and AFs inTac1 knockout mice. Of note,
these data inTac1 null mice suggest that compensation by
other tachykinins, eg, NKB, does not occur in this model.
In fact, we have observed similar Tac2 mRNA levels (en-
codingNKB in rodents) inMBH samples of adultWT and
Tac1 null male mice (data not shown) that support this
contention, although further characterization of all tachy-
kinin ligand-receptor systems needs to be performed in the
female. Nonetheless, the data mentioned above, together
with the significantly reduced litter size in SP-deficient
mice, indicate a level of subfertility in the absence of SP,
whichmay be, at least in part, due to an impairment in the
positive feedback action of sex steroids. Along these lines,
SP levels have been described to fluctuate in the hypothal-
amus of rats during the estrous cycle (42), and we have
documented that Tac1 expression in the ARC and ven-
tromedial nucleus is inhibited by E2 (25), in agreement
with previous studies showing increased SP levels in hy-
pothalami of postmenopausalwomen (43). These data are
also in agreement with human and monkey studies dem-
onstrating that plasma SP levels vary across the menstrual
cycle, with higher levels of SP during the follicular phase
that correlatednegativelywith theE2 levels (44, 45).How-
ever, the site of origin of the SP measured in the serum in
these studies is unknown. Altogether, these studies sup-
port a role for this tachykinin in the control of the gonad-
otropic axis, at least in part by regulating kisspeptin re-
lease centrally.
The identification of all the potential site/s of action of
SP for its reproductive role remains to be fully deciphered.
Strong evidence indicates that SP can activate the gonad-
otropic axis centrally because, first, central activation of
the SP receptor (NK1R) causes a robust gonadotropin in-
duction (that is prevented in the absence of kisspeptin)
(25), and second, SP activates Kiss1 neurons (23). Admit-
tedly, given the expression of Tac1 in other areas of the
brain, eg, VMH and lateral hypothalamus (25), the pos-
sibility that these populations ofTac1 neurons outside the
ARC also play a role in the control of kisspeptin/GnRH
release cannot be excluded.
Supporting the role of SP in the central control of pu-
berty onset is the fact that higher SP levels detected in the
brain of patients after traumatic brain injury (46–48) cor-
relate with the significantly higher ratio of children dis-
playing precocious puberty after traumatic brain injury
(49, 50). This correlationmay suggest a causative effect of
higher central SP levels on earlier pubertal onset (repli-
cated by our present data in prepubertal female mice) and
support a role for SP in the control of the gonadotropic
axis across species.
Nonetheless, despite the compelling evidence for a cen-
tral role of SP, we cannot rule out the possibility of actions
of SP in other organs of the gonadotropic axis, such as the
ovary. Indeed, SP and NK1R have been identified in the
mouse ovary (51, 52) and could, potentially, contribute to
the subfertility phenotype observed in SP deficient female
mice.
In summary, we offer evidence that supports a role for
the SP/NK1R system in the activation of the gonadotropic
axis to trigger puberty onset and the attainment of full
reproductive capabilities, at least in the female mouse.
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